Why The DOL Proposed Rule Offers No Additional Meaningful Transparency
PBM Reform is Law – DOL Should Withdraw Its Duplicative Proposal The Department of Labor’s proposed rule on “Improving Transparency into Pharmacy Benefit Manager Fee Disclosure”
How PBMs Provide Unique Capabilities to Fight Fraud, Waste, and Abuse
PCMA Urges CMS to Partner with PBMs to Strengthen Real-Time Fraud Detection Fraud, waste, and abuse in the health care system drive up costs for patients, employers, and
PCMA Submits Comments on Interoperability and AI
Last week, PCMA submitted comments to the U.S. Department of Health and Human Services on a proposed interoperability rule that would make significant changes to the Office of the National Health Coordinator (ONC)
PCMA Comments on Proposed Drug Pricing Regulations
Yesterday, PCMA submitted comments on the proposed Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE) models, warning that meaningful transparency is
PCMA Provides Recommendations for 2027 Medicare Plan Year to Streamline Regulations and Stabilize the MA Market to Provide A Better Patient Experience
As part of PCMA’s efforts to advocate for regulatory policies that enable better health outcomes and increase access to life-saving medications, the organization submitted comments to the Centers for
